Press releaseNewsfile
Adia Nutrition
ADIA · OTC
$0.12−$0.01 (−7.69%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseNewsfile
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position
- Press releaseNewsfile
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
- Press releaseNewsfile
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
- Press releaseNewsfile
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
- Press releaseNewsfile
Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment
- Press releaseNewsfile
Nasdaq Shareholder Requirements Just Verified By Adia Med
- Press releaseNewsfile
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
- Press releaseNewsfile
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
- Press releaseNewsfile
Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half
- Press releaseNewsfile
Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing
- Press releaseNewsfile
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
- Press releaseNewsfile
Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
- Press releaseNewsfile
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
- Press releaseNewsfile
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
- Press releaseNewsfile
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review
- Press releaseNewsfile
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
- Press releaseNewsfile
Adia Med Finds Another Unicorn
- Press releaseNewsfile
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
- Press releaseNewsfile
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
- Press releaseNewsfile
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
- Press releaseNewsfile
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
- Press releaseNewsfile
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
- Press releaseNewsfile
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
- Press releaseNewsfile
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
- Press releaseNewsfile
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
- Press releaseNewsfile
Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model
- Press releaseGlobe Newswire
Stem Cells, Superstars, And Supershow: WWE Superstar Elias Set to Face Off at WrestleCade SuperShow 2024 This Weekend
- Press releaseGlobe Newswire
Adia Nutrition Inc. Takes Major Steps Forward: Signs LOI for First Clinic and Engages Legal Expertise for Licensing
- Press releaseNewsfile
Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio with Organic Protein and Mushroom Coffee
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.